Max Jonson

Max Jonson is currently Director at BioLamina AB, Bure Growth AB, and Skanditek AB. Mr. Jonson is Chief Financial Officer at Bure Equity AB and Bure Equity since 2013.
Former roles include Director at Celemiab Group AB (2014–2016), Dipylon Medical AB (2016–2017), Atle Investment Management AB, and Celemi International AB (2016–2018).
Mr. Jonson was Associate Director-Corporate Finance at SEB Group (Sweden) from 1996 to 2003.
Other former positions include Chief Financial Officer at Orasolv AB (2011–2012), Stockholm School of Economics Ifl (2012–2013), Sse Executive Education (2012–2013), and ACQ Bure AB. Mr. Jonson was Finance Manager at Dpnova AB (2011–2013) and held a Chief Financial Officer role at Yubico AB. Education includes an MBA from The University of Chicago and undergraduate studies at New York University.